Tag: clinical milestones

May 9, 2018

AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates

AnaptysBio (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, reported operating...
March 28, 2018

Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates

Mersana Therapeutics (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based...
January 25, 2018

Actinium Pharmaceuticals Issues Letter to Investors Providing Company Update and Outlook for 2018

Actinium Pharmaceuticals (NYSE:ATNM) announced that it has issued a letter to investors providing a company update and outlook for 2018. As quoted...
January 22, 2018

Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura

Anthera Pharmaceuticals (Nasdaq:ANTH) today announced a positive outcome of the second, pre-specified interim futility analysis for the RESULT Phase 3...
March 6, 2017

Stellar Biotechnologies enters exclusive agreement with Amaran Biotechnology

Stellar Biotechnologies (NASDAQ:SBOT) and Amaran Biotechnology signed an exclusive agreement where Stellar will supply of keyhole limpet hemocyanin (KLH) to...
November 9, 2016

Kadmon Provides Business Update and Reports Third Quarter 2016 Financial Results

Kadmon Holdings today provided a business update, including a review of near-term clinical milestones, and reported financial and operational results...
September 29, 2016

Evotec Receives Further Important Pre-Clinical Milestone in Endometriosis Alliance with Bayer

Evotec announced today that its multi-target endometriosis alliance with Bayer has reached another key pre-clinical milestone for the transition of...